top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advance in the Treatment of Pediatric Leukemia
Advance in the Treatment of Pediatric Leukemia
Autore Handgretinger Rupert
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (300 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato acute lymphoblastic leukemia
pediatric
advances
diagnosis
treatment
immunotherapy
bispecific T-cell engager (BiTE)
BCP-ALL
leukemia
TRAIL
antibody
Fc-engineering
xenograft
CD19
juvenile myelomonocytic leukemia
RAS signaling
hematopoietic stem cell transplantation
5-azacitidine
myelodysplastic/myeloproliferative disorders
targeted therapy
ADC
antibody-drug conjugate
pediatric leukemia
ALL
AML
allogeneic stem cell transplantation
acute myeloid leukemia
minimal residual disease
conditioning regimen
alternative donors
B-ALL
DUX4
IKZF1
PAX5
Ph-like
ZNF384
NUTM1
T-ALL
NOTCH1
BCL11B
transcriptome
genome
chronic myeloid leukemia
CML
tyrosine kinase inhibitor
immunizations
COVID-19
childhood acute lymphoblastic leukemia
low-risk ALL
risk-stratified treatment
treatment related toxicity
L-asparaginase
acute pancreatitis
polymorphism
SNV
ABCC4
CFTR
other extramedullary relapse
lymphoblastic leukemia
children
prognosis
evolution of CAR T cells
FDA-approved CAR products
TcR versus CAR
limitations and complications of CAR T cell therapy
future directions of CAR T cell therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576878903321
Handgretinger Rupert  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Experimental and Clinical Treatment of Subarachnoid Hemorrhage after Rupture of Saccular Intracranial Aneurysms
Experimental and Clinical Treatment of Subarachnoid Hemorrhage after Rupture of Saccular Intracranial Aneurysms
Autore Marbacher Serge
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (132 p.)
Soggetto topico Medicine
Surgery
Soggetto non controllato syncope
acute myeloid leukemia
intracranial hemorrhage
hyperleukocytosis
blast crisis
subarachnoid hemorrhage
IL-1α
inflammation
animal model
growth
aneurysm rupture
saccular
intracranial aneurysm
aneurysm
cerebral aneurysm
aneurysmal subarachnoid hemorrhage
delayed cerebral vasospasm
ischemic stroke
Sartans
therapeutic interventions
ventriculomegaly
diffusion tensor imaging
corticospinal tract
decellularization
rabbits
vessel wall
aneurysm clipping
posterior circulation aneurysm
temporary balloon occlusion
intraoperative digital subtraction angiography
hybrid operating room
estrogen
female
endothelial cell
macrophage
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557703503321
Marbacher Serge  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrative Multi-Omics in Biomedical Research
Integrative Multi-Omics in Biomedical Research
Autore Gerner Christopher
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (178 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato target identification
target validation
label-free method for drugs
anti-angiogenesis
mechanism of action
receptor tyrosine kinases
curcumin
natural products
lipid
lipidomics
cardiac metaplasia
Barrett's esophagus
esophageal adenocarcinoma
microbiota
DNA sensing
IFI16
cGAS
innate immunity
protein interactions
virus-host interactions
post-translational modifications
mass spectrometry
proteomics
transcriptomics
multi-omics
multi-omics analysis
study design
bioinformatics
machine learning
analysis flow
metabolomics
planned myocardial infarction (PMI)
myocardial infarction (MI)
exercise
heart
cheminformatics
batch variations
eicosanoids
fetal calf serum
peroxisomes
host-pathogen interactions
secretome
macrophages
acute myeloid leukemia
HL-60 cell line
ATRA
induced differentiation
transcriptome
proteome
transcription factors
key molecules
regulatory pathway modelling
SRM
endometriosis
inflammation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557769003321
Gerner Christopher  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
mTOR in Human Diseases
mTOR in Human Diseases
Autore Dormond Olivier
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (480 p.)
Soggetto non controllato primary cilia
neurodegeneration
nutrient sensor
PI3K
transcriptomics
phosphorylation
metabolic reprogramming
autophagy
Alzheimer's disease
rapalogs
liver
angiogenesis
mTOR complex
MBSCs
advanced biliary tract cancers
Medulloblastoma
epithelial to mesenchymal transition
AMPK
p70S6K
lipid metabolism
thyroid cancer
sodium iodide symporter (NIS)/SLC5A5
male fertility
anesthesia
illumina
mTOR inhibitor
miRNA
Hutchinson-Gilford progeria syndrome (HGPS)
eIFs
Emery-Dreifuss muscular dystrophy (EDMD)
glucose
AKT
oral cavity squamous cell carcinoma (OSCC)
glucose and lipid metabolism
cellular signaling
aging
tumor microenvironment
rapamycin
leukemia
chloral hydrate
rapalogues
schizophrenia
T-cell acute lymphoblastic leukemia
senescence
lamin A/C
neurotoxicity
neurodevelopment
inhibitor
methamphetamine
pulmonary fibrosis
mTOR
mTOR inhibitors
combination therapy
proteolysis
fluid shear stress
tumour cachexia
biomarkers
synapse
gluconeogenesis
mTOR signal pathway
Sertoli cells
immunosenescence
miRNome
protein aggregation
senolytics
metabolism
NGS
mTORC2
mTORC1
metabolic diseases
IonTorrent
apoptosis
dopamine receptor
nocodazole
microenvironment
everolimus
acute myeloid leukemia
immunotherapy
spermatogenesis
bone remodeling
signalling
targeted therapy
ageing
therapy
NVP-BEZ235
fructose
physical activity
laminopathies
MC3T3-E1 cells
cell signaling
microRNA
cancer
lipolysis
melatonin
Parkinson's disease
ISBN 3-03921-061-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346684303321
Dormond Olivier  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Developments in Cancer Systems Biology
Recent Developments in Cancer Systems Biology
Autore Sinha Raghu
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (272 p.)
Soggetto topico Medicine
Soggetto non controllato Sestrin2
lung cancer
knockdown
cancer progression
bioinformatics
patient survival
lung adenocarcinoma
circulating miR-1246
glycosaminoglycan binding
prognosis
PI3K-Akt signaling pathways
TargetScan
UBE2C
cancer systems biology
experimental model systems
next-generation sequencing
single-cell sequencing
patient-derived xenografts
patient-derived organoids
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
ETS
Elk-1
stem cell
microarray
brain-tumor-initiating cell (BTIC)
pancreatic cancer
systems biology
omics
biomarker
genomics
transcriptomics
proteomics
metabolomics
glycomics
metagenomics
Ets
PEA3
Ets-1
glioma
optical genome mapping
solid tumors
cancer genomics
breast
ovarian
cancer
TCGA
non-small-cell lung cancer
lung adenocarcinoma (LUAD)
lung squamous cell carcinoma (LUSC)
differential expression
SNV
CNV
risk group
signature
survival
renal cancers
protein interactome
diagnostic biomarker
prognostic biomarker
virtual screening
docking
acute myeloid leukemia
Boolean model
drug resistance
network
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557768503321
Sinha Raghu  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Autore Luparello Claudio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (318 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato berberine
signaling pathways
oncogenic cascades
TRAIL
microRNAs
cancer therapy
colon cancer cells
ethanol
Nrf2
HO-1
ER stress
autophagy
MMPs
formononetin
cancer
preclinical models
cell signaling
angiogenesis
nobiletin
colorectal cancer
chemoprevention
bioactivities
experimental therapeutics
HDAC
multiple myeloma
oleacein
breast cancer
persistent organic pollutants
breast cancer risk
breast cancer prognostic
systematic review
carrageenan
invasion
metastasis
RacGAP1
radiotherapy
marine sponge
natural product
anticancer drug
oral cancer inhibition
phytochemicals
small organic agents
Piper eriopodon, alkenylphenols
human cancer cells
cell death
apoptosis
caspase-independent cell death
XIAP antagonists
XIAP-BIR3 domain
Calocedrus formosana
lung cancer
yatein
cell-cycle arrest
xenograft
isorhamnetin
G2/M arrest
ROS
AMPK
pancreatic cancer
epigallocatechin-3-gallate (EGCG)
gemcitabine
glycolysis
phosphofructokinase
natural polyphenols
anticancer activities
molecular mechanisms
Streptomyces
mangrove
anti-proliferative
colon cancer
epithelial mesenchymal transition
inflammation
malignant cancer
natural anti-inflammatory compounds
pro-resolving lipids
anticancer drugs
flavonoids
natural compounds
Xenopus laevis
AOM/DSS model
melanoma cells
nicotine
α9-nAChR
PD-L1
STAT3
gigantol
AKT
JAK/STAT
cancer stem cell
tumor maintenance
tumor density
proteomics
honokiol
anticancer
mechanism
signalling pathway
uterine sarcoma
fucoidan
isobolography
colchicine alkaloid
mesoporous silica nanoparticles
targeted delivery system
PD-1 immune checkpoint inhibitor and cancer immunotherapy
glucose transport
drugs
innate immunity
β-glucans
nutrition
immunotherapy
estrogen
estrogen receptor alpha
polyphenols
daidzein
daidzein metabolites
paclitaxel
breast cancer cells
obesity
renin-angiotensin system
eicosapentaenoic acid
adipocyte inflammation
olive leaf extract
oleuropein
Seahorse analysis
cancer metabolism
glycolytic markers
Malva pseudolavatera Webb &
Berthel
acute myeloid leukemia
reactive oxygen species
brain cancer
gliomas
schwannomas
malignant tumors of the peripheral nerve sheath (MPNST)
neurofibromas
bioavailability
nanoparticle-based delivery systems
natural bioactive compound
gallic acid
EGFR signaling
p53
EGCG
non-coding RNAs
anti-cancer drug
NSCLC
EGFR TKI
FASN inhibitors
resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of Natural Bioactive Compounds in the Rise and Fall of Cancers
Record Nr. UNINA-9910557476303321
Luparello Claudio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui